SAN DIEGO --(BUSINESS WIRE)--Nov. 26, 2019-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conference: Steven Pacelli , Executive Vice President, Strategy and Corporate Development, will present an update on the

SAN DIEGO --(BUSINESS WIRE)--Nov. 8, 2019-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli , Executive Vice President, Strategy and Corporate Development, will present an update on the company

SAN DIEGO --(BUSINESS WIRE)--Nov. 6, 2019-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2019 . Third Quarter 2019 Highlights: Revenue grew 49% versus the same quarter of the prior year to $396.3 million U.S.

  SAN DIEGO --(BUSINESS WIRE)--Oct. 9, 2019-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2019 financial results after market close on Wednesday, November 6, 2019 . Management will hold a conference call to review the company's third quarter 2019

  First and only single-use, professional CGM system with blinded or unblinded mode     SAN DIEGO --(BUSINESS WIRE)--Oct. 8, 2019-- Dexcom, Inc. (NASDAQ:DXCM) announced today the U.S. Food and Drug Administration ( FDA ) has cleared the Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System for

SAN DIEGO --(BUSINESS WIRE)--Sep. 17, 2019-- DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the promotion of Quentin Blackford to the role of Chief Operating Officer (COO) in addition to his duties as Chief Financial Officer. Mr.

SAN DIEGO --(BUSINESS WIRE)--Sep. 17, 2019-- DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Bridgette Heller to its Board of Directors, effective immediately. Ms. Heller brings more than 35 years of experience at Fortune

Revolutionary new Continuous Glucose Monitoring System eliminates fingersticks* for people with diabetes VANCOUVER , Sept. 9, 2019 /CNW/ - DexCom  Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today that it is now accepting orders for the Dexcom G6 CGM System for

SAN DIEGO --(BUSINESS WIRE)--Aug. 23, 2019-- The U.S. District Court for the District of Oregon has granted Dexcom's (NASDAQ:DXCM) motion for summary judgment invalidating all asserted claims in the two remaining patents asserted against it by WaveForm Technologies, Inc.

SAN DIEGO --(BUSINESS WIRE)--Aug. 2, 2019-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conferences: Quentin Blackford , Executive Vice President and Chief Financial Officer, and Steven Pacelli , Executive Vice